Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thrombosis 3Pulmonary Embolism 3Neoplasms 3Venous Thromboembolism 2Thrombosis 1Myeloproliferative Disorders 1

Interventions

apixaban 17Dalteparin 12Rivaroxaban 11Heparin, Low-Molecular-Weight 8Enoxaparin 8Aspirin 8Tinzaparin 6Nadroparin 3Fondaparinux 3Warfarin 2Rosuvastatin Calcium 2Observation 2Dabigatran 2sotorasib 1ribociclib 1reviparin 1palbociclib 1enoxaparin sodium 1edoxaban 1certoparin 1bemiparin 1argatroban 1acarboxyprothrombin 1abemaciclib 1Tacrolimus 1Tablets 1Surveys and Questionnaires 1Simvastatin 1Platelet Transfusion 1Phenprocoumon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Venous Thromboembolism × Dabigatran × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡